The demand for cannabis in medicine is growing rapidly. Australia plans to spend $2.03 million in research on the use of cannabis. They want to check how this healing herb may help cancer patients.
Australia will fund research on medicinal cannabis
Patients in most parts of Australia may use such products by prescription. The main point is that they should have a license only if people grow and produce medicinal cannabis. Australian Health Minister Greg Hunt said that 11,000 patients have no access to medicinal cannabis with most prescriptions issued this year.
There has been only a limited number of well-planned clinical trials of medicinal cannabis. We need to increase the evidence base to support the actions of health professionals.
Who has a license for growing and collecting medicinal cannabis
The most obvious reason is the criminal implications. To tell the truth, cultivating illegal cannabis is still a serious offense in all states and territories of Australia. Data from the Ministry of Health shows that 78 companies currently have licenses to grow and collect medicinal cannabis.
Olivia Newton-John, an Australian singer and actress of English origin, became a strong advocate for the use of medical cannabis after she found out she had cancer. “I am a supporter of this for general health, for better sleep, for pain and anxiety.”
Newton-John’s efforts shine a light on the benefits of using medicinal cannabis. The government will work to ensure that Australian patients have access to it.
Government position on medicinal cannabis use
The government is unlikely to change its position with regard to the use of cannabis for recreational purposes. At the end of September, the Australian Capital Territory became the first of the six states in the country to legalize cannabis for personal use. The Australian capital has legalized marijuana for personal use. This is contrary to national drug laws, which prohibit possession of marijuana.
Attorney-General Christian Porter is awaiting a copy of the final version of the ACT bill before deciding whether the federal government should override the territory legislation, the Weekend Australian newspaper said on Saturday.
How to access medicinal cannabis in Australia
In October 2016, the Narcotic Drugs Amendment Act 2016 came into effect in Australia, allowing doctors to legally prescribe medicinal cannabis to patients with specific medical conditions through the Therapeutic Goods Administration (TGA)’s Special Access Scheme. Dr. Agarwal said since legalization occurred, there has been an increased “softening of the regulations to prove eligibility for medical use”. “It’s federally open – it’s the same essentially everywhere he said.
“Some people say there’s a patient access problem but it’s not really a government problem anymore; it’s more a function of cost or efficiencies of the system,” Dr. Agarwal added. The medical conditions that cannabis can be prescribed for are quite extensive – but you can’t use it to treat the common cold.
Clinical trials and medical research has shown medicinal cannabis can assist in the treatment of symptoms for conditions including but not limited to: chronic pain syndrome; neurological conditions such as epilepsy; multiple sclerosis and motor neuron diseases; inflammatory bowel diseases, Crohn’s disease, and ulcerative colitis; chronic cancer pain and malaise; chemotherapy-induced nausea and vomiting; arthritis; and dementia.
(Featured image by Creators Collective)
First published in thebabel, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. B2I assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. B2I is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Another biotech gem from Switzerland secures growth capital
A biotech spin-off from the Universities of Zurich and Basel has received new funds from a financing round with renowned...
Industrial espionage costs German companies $229.4 billion
According to the Federation of German Industries (BDI), data theft, industrial espionage and sabotage have cost German companies $229.1 billion...
French Real Estate Crowdfunding grew by 80% in 2019
Real estate crowdfunding is a new way for investors to raise money for their affairs. Crowdfunding for real estate brings...
Growing Capacity: Why Smart Expansion Is Key To Success Among Cannabis Growers
Soaring demand is driving the cannabis market to new highs, as thousands of under served clients can finally obtain their...
Investors react to the Sanofi-Regeneron collaboration
Regeneron Pharmaceuticals Inc shares rebounded as investors found out about collaboration partner Sanofi SA’s liquidation of its Regeneron stake. The...
- Crypto6 days ago
Swiss licensed crypto bank is expanding into 9 new markets
- Biotech7 days ago
Geman Biotech Stocks: Mologen (MGNK) goes insolvent while MorphoSys (MOR) strengthens its position
- Business4 days ago
Where Social Media is Headed in 2020
- Cannabis7 days ago
Brazilian health authority approves registration of cannabis medicines